3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients
Leave reply:
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Follow Kairos Ventures on LinkedIn
Subscribe to Kairos News
Recent Posts
- Actuate Therapeutics Announces Positive Interim Phase 2 Data of Elraglusib in First Line Treatment of Metastatic Pancreatic Cancer
- GuRu Wireless Establishes Advisory Board to Advance Deployment of its Long-Range Wireless Power Transfer Technology in Cutting-Edge Applications
- Babcock, PteroDynamics sign agreement to collaborate on UAS
- Actuate Therapeutics to be Added to Russell 2000® Index
- Godrej Agrovet Partners with Provivi to Revolutionize Pest Control in India